New Drug for Cancer Radiation Therapy That Minimizes Damage to Healthy Tissue, Developed by Kyoto University Spin-off RadioNano, Secures Funding for Clinical Trials

RadioNano Therapeutics, which is engaged in the research and development of inorganic nanoparticle formulations for Boron Neutron Capture Therapy (BNCT), announced on the 9th that it has completed the first close of its Series B round through a third-party allotment of shares to Mitsui Kinzoku and Kyoto University Innovation Capital. Read more. The amount raised has not been disclosed. The company is a Kyoto University spin-off aiming to implement neutron capture therapy using boron-containing n

NewsBeagle is a discovery engine. We show the headline, a short source-supplied summary and clear attribution. The complete reporting remains with the publisher.